245 related articles for article (PubMed ID: 33820459)
1. Pharmacogenomics in the era of next generation sequencing - from byte to bedside.
Russell LE; Zhou Y; Almousa AA; Sodhi JK; Nwabufo CK; Lauschke VM
Drug Metab Rev; 2021 May; 53(2):253-278. PubMed ID: 33820459
[TBL] [Abstract][Full Text] [Related]
2. Computational Tools to Assess the Functional Consequences of Rare and Noncoding Pharmacogenetic Variability.
Zhou Y; Lauschke VM
Clin Pharmacol Ther; 2021 Sep; 110(3):626-636. PubMed ID: 33998671
[TBL] [Abstract][Full Text] [Related]
3. Challenges Related to the Use of Next-Generation Sequencing for the Optimization of Drug Therapy.
Zhou Y; Lauschke VM
Handb Exp Pharmacol; 2023; 280():237-260. PubMed ID: 35792943
[TBL] [Abstract][Full Text] [Related]
4. Next-generation sequencing in pharmacogenomics - fit for clinical decision support?
Zhou Y; Lauschke VM
Expert Rev Clin Pharmacol; 2024 Mar; 17(3):213-223. PubMed ID: 38247431
[TBL] [Abstract][Full Text] [Related]
5. A paradigm shift in pharmacogenomics: From candidate polymorphisms to comprehensive sequencing.
Zhou Y; Koutsilieri S; Eliasson E; Lauschke VM
Basic Clin Pharmacol Toxicol; 2022 Dec; 131(6):452-464. PubMed ID: 35971800
[TBL] [Abstract][Full Text] [Related]
6. Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing.
Lauschke VM; Ingelman-Sundberg M
Eur J Pharm Sci; 2019 Mar; 130():65-77. PubMed ID: 30684656
[TBL] [Abstract][Full Text] [Related]
7. Challenges and opportunities associated with rare-variant pharmacogenomics.
Zhou Y; Tremmel R; Schaeffeler E; Schwab M; Lauschke VM
Trends Pharmacol Sci; 2022 Oct; 43(10):852-865. PubMed ID: 36008164
[TBL] [Abstract][Full Text] [Related]
8. Requirements for comprehensive pharmacogenetic genotyping platforms.
Lauschke VM; Ingelman-Sundberg M
Pharmacogenomics; 2016 Jun; 17(8):917-24. PubMed ID: 27248710
[TBL] [Abstract][Full Text] [Related]
9. Variant discovery using next-generation sequencing and its future role in pharmacogenetics.
Russell LE; Schwarz UI
Pharmacogenomics; 2020 May; 21(7):471-486. PubMed ID: 32338137
[TBL] [Abstract][Full Text] [Related]
10. The Role of Next-Generation Sequencing in Pharmacogenetics and Pharmacogenomics.
Schwarz UI; Gulilat M; Kim RB
Cold Spring Harb Perspect Med; 2019 Feb; 9(2):. PubMed ID: 29844222
[TBL] [Abstract][Full Text] [Related]
11. Emerging strategies to bridge the gap between pharmacogenomic research and its clinical implementation.
Lauschke VM; Ingelman-Sundberg M
NPJ Genom Med; 2020; 5():9. PubMed ID: 32194983
[TBL] [Abstract][Full Text] [Related]
12. Current status of the analytical validation of next generation sequencing applications for pharmacogenetic profiling.
Huebner T; Steffens M; Scholl C
Mol Biol Rep; 2023 Nov; 50(11):9587-9599. PubMed ID: 37787843
[TBL] [Abstract][Full Text] [Related]
13. Results of the implementation of a pharmacogenomics platform based on NGS technologies. Combining clinical and research approaches.
Ramudo-Cela L; Busto-Fernández F; Outeda-Macías M; Antolín S; Calvo-Martínez L; Martín-Herranz I
Farm Hosp; 2021 Dec; 45(7):11-37. PubMed ID: 35379108
[TBL] [Abstract][Full Text] [Related]
14. Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer.
Morganti S; Tarantino P; Ferraro E; D'Amico P; Duso BA; Curigliano G
Adv Exp Med Biol; 2019; 1168():9-30. PubMed ID: 31713162
[TBL] [Abstract][Full Text] [Related]
15. Deciphering next-generation pharmacogenomics: an information technology perspective.
Potamias G; Lakiotaki K; Katsila T; Lee MT; Topouzis S; Cooper DN; Patrinos GP
Open Biol; 2014 Jul; 4(7):. PubMed ID: 25030607
[TBL] [Abstract][Full Text] [Related]
16. Targeted Next-Generation Sequencing for Comprehensive Genetic Profiling of Pharmacogenes.
Han SM; Park J; Lee JH; Lee SS; Kim H; Han H; Kim Y; Yi S; Cho JY; Jang IJ; Lee MG
Clin Pharmacol Ther; 2017 Mar; 101(3):396-405. PubMed ID: 27727443
[TBL] [Abstract][Full Text] [Related]
17. The Use of Next-Generation Sequencing in Pharmacogenomics.
Enko D; Michaelis S; Schneider C; Schaflinger E; Baranyi A; Schnedl WJ; Muller DJ
Clin Lab; 2023 Aug; 69(8):. PubMed ID: 37560847
[TBL] [Abstract][Full Text] [Related]
18. Towards population-specific pharmacogenomics in the era of next-generation sequencing.
Ji X; Ning B; Liu J; Roberts R; Lesko L; Tong W; Liu Z; Shi T
Drug Discov Today; 2021 Aug; 26(8):1776-1783. PubMed ID: 33892143
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine.
Ji Y; Si Y; McMillin GA; Lyon E
Expert Rev Mol Diagn; 2018 May; 18(5):411-421. PubMed ID: 29634383
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetic and pharmacogenomic discovery strategies.
Crisafulli C; Romeo PD; Calabrò M; Epasto LM; Alberti S
Cancer Drug Resist; 2019; 2(2):225-241. PubMed ID: 35582724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
